Corporate calendar for Enveric Biosciences, Inc. (ENVB): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | $144M | |
| 2026-09-14 | $898M |
Dividend History
| Date | Amount | Yield |
|---|---|---|
| 2008-04-23 | $0.0210 | 5.64% |
Stock Splits
| Date | Ratio |
|---|---|
| 2025-10-28 | 1:12 |
| 2022-07-15 | 1:50 |
| 2020-12-31 | 1:4 |
| 2019-11-25 | 1:25 |
| 2015-05-26 | 1000:17609 |
| 2008-12-17 | 1:10 |
Price
| Price | $1.49 |
| Market Cap | $1M |
| Exchange | NASDAQ |
| Country | US |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 3 |
| Hold | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 4 |
| Avg rating (1-5) | 0.75 |
Related companies: AZTR · HEPA · INDP · JSPR · ONCO · SCNI · SLRX
Explore sector: Healthcare · Biotechnology
More sections of ENVB: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks